Full text
PDF![1500](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a87/2549877/83e83d3ae28f/bmj00596-0026.png)
![1501](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a87/2549877/8fa53b5f4057/bmj00596-0027.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Grandinetti A., Morens D. M., Reed D., MacEachern D. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol. 1994 Jun 15;139(12):1129–1138. doi: 10.1093/oxfordjournals.aje.a116960. [DOI] [PubMed] [Google Scholar]
- Jansson B., Jankovic J. Low cancer rates among patients with Parkinson's disease. Ann Neurol. 1985 May;17(5):505–509. doi: 10.1002/ana.410170514. [DOI] [PubMed] [Google Scholar]
- Kochar A. S. Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature. Am J Med. 1985 Jul;79(1):119–121. doi: 10.1016/0002-9343(85)90555-8. [DOI] [PubMed] [Google Scholar]
- Wick M. M., Frei E., 3rd Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro. Cancer Res. 1977 Jul;37(7 Pt 1):2123–2125. [PubMed] [Google Scholar]